Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 31, 2016 13:41 ET | Source: Microlin Bio, Inc.

Microlin Bio, Inc. to Present at 2016 Marcum MicroCap Conference

NEW YORK, May 31, 2016 (GLOBE NEWSWIRE) -- Microlin Bio, Inc.(OTCQB:MICB), a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, today...
May 02, 2016 23:41 ET | Source: Microlin Bio, Inc.

Microlin Bio, Inc. Announces Termination of Planned Marina Biotech Asset Purchase

NEW YORK, May 02, 2016 (GLOBE NEWSWIRE) -- Microlin Bio, Inc. (OTCQB:MICB), a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, today...
February 10, 2016 11:55 ET | Source: Microlin Bio, Inc.

Microlin Bio Signs Exclusive License and Research Agreement With Université Laval to Develop microRNA-Based Treatments for Alzheimer’s Disease

NEW YORK and QUEBEC CITY, Feb. 10, 2016 (GLOBE NEWSWIRE) -- Microlin Bio, Inc. (Microlin) (OTCBB:MICB) and Université Laval, today announced that they have entered into an exclusive license and...
January 14, 2016 09:28 ET | Source: Microlin Bio, Inc.

Microlin Bio, Inc. Announces Ticker Symbol Change to MICB

NEW YORK, Jan. 14, 2016 (GLOBE NEWSWIRE) -- Microlin Bio, Inc., a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, today announced the...
January 12, 2016 08:00 ET | Source: Microlin Bio, Inc.

Microlin Bio, Inc. Announces Publication of Results From AntimiR-21 Lung Cancer Study in Molecular Pharmaceutics

NEW YORK, Jan. 12, 2016 (GLOBE NEWSWIRE) -- Microlin Bio, Inc.(OTCQB:AMIB), a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, today...
December 22, 2015 16:30 ET | Source: Microlin Bio, Inc.

Microlin Bio, Inc. Completes Reverse Merger and Becomes a Publicly Traded Company

NEW YORK, Dec. 22, 2015 (GLOBE NEWSWIRE) -- Microlin Bio, Inc., a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, today announced the...